First Patient Expected News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from First Patient Expected. Real-time updates on events, politics, business and more.

NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

February 29, 2024

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today...

United States United Kingdom Michael Miller Alexander Prezioso Marshallh Woodworth Donga St Co

Source: prnewswire.com

Aura Biosciences Reports Second Quarter 2023 Financial Results and Provides Clinical Development and

August 9, 2023

Strengthened Clinical and Regulatory Leadership Team with Key AppointmentsStart-up Activities for the Global Phase 3 Trial Ongoing with Release of Drug Product Manufactured with Commercial Process and First Patient Expected to be Dosed in 2H 2023BOSTON--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinic...

United States Anthony Daniels Bruce Brown Los Pinos Richard Mountfield Oncology Division

Source: pharmiweb.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

First Patient Expected News Today

NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

Aura Biosciences Reports Second Quarter 2023 Financial Results and Provides Clinical Development and

Explore More Categories